NM_004655.4:c.2141+73G>A
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_004655.4(AXIN2):c.2141+73G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0625 in 1,452,374 control chromosomes in the GnomAD database, including 3,187 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.054 ( 287 hom., cov: 33)
Exomes 𝑓: 0.063 ( 2900 hom. )
Consequence
AXIN2
NM_004655.4 intron
NM_004655.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.00700
Publications
8 publications found
Genes affected
AXIN2 (HGNC:904): (axin 2) The Axin-related protein, Axin2, presumably plays an important role in the regulation of the stability of beta-catenin in the Wnt signaling pathway, like its rodent homologs, mouse conductin/rat axil. In mouse, conductin organizes a multiprotein complex of APC (adenomatous polyposis of the colon), beta-catenin, glycogen synthase kinase 3-beta, and conductin, which leads to the degradation of beta-catenin. Apparently, the deregulation of beta-catenin is an important event in the genesis of a number of malignancies. The AXIN2 gene has been mapped to 17q23-q24, a region that shows frequent loss of heterozygosity in breast cancer, neuroblastoma, and other tumors. Mutations in this gene have been associated with colorectal cancer with defective mismatch repair. [provided by RefSeq, Jul 2008]
AXIN2 Gene-Disease associations (from GenCC):
- oligodontia-cancer predisposition syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
- tooth agenesisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- craniosynostosisInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.71).
BP6
Variant 17-65536247-C-T is Benign according to our data. Variant chr17-65536247-C-T is described in ClinVar as Benign. ClinVar VariationId is 1247170.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.108 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| AXIN2 | ENST00000307078.10 | c.2141+73G>A | intron_variant | Intron 8 of 10 | 1 | NM_004655.4 | ENSP00000302625.5 | |||
| AXIN2 | ENST00000375702.5 | c.1946+73G>A | intron_variant | Intron 6 of 8 | 1 | ENSP00000364854.5 | ||||
| AXIN2 | ENST00000618960.4 | c.1946+73G>A | intron_variant | Intron 7 of 9 | 5 | ENSP00000478916.1 | ||||
| AXIN2 | ENST00000578251.1 | n.363+73G>A | intron_variant | Intron 1 of 2 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0545 AC: 8287AN: 152190Hom.: 289 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
8287
AN:
152190
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0635 AC: 82512AN: 1300066Hom.: 2900 AF XY: 0.0656 AC XY: 42360AN XY: 646218 show subpopulations
GnomAD4 exome
AF:
AC:
82512
AN:
1300066
Hom.:
AF XY:
AC XY:
42360
AN XY:
646218
show subpopulations
African (AFR)
AF:
AC:
658
AN:
29704
American (AMR)
AF:
AC:
1080
AN:
35600
Ashkenazi Jewish (ASJ)
AF:
AC:
1336
AN:
24516
East Asian (EAS)
AF:
AC:
2732
AN:
35634
South Asian (SAS)
AF:
AC:
9305
AN:
77238
European-Finnish (FIN)
AF:
AC:
4724
AN:
48648
Middle Eastern (MID)
AF:
AC:
351
AN:
3926
European-Non Finnish (NFE)
AF:
AC:
58590
AN:
990174
Other (OTH)
AF:
AC:
3736
AN:
54626
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
4139
8278
12417
16556
20695
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
2166
4332
6498
8664
10830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0544 AC: 8282AN: 152308Hom.: 287 Cov.: 33 AF XY: 0.0574 AC XY: 4273AN XY: 74466 show subpopulations
GnomAD4 genome
AF:
AC:
8282
AN:
152308
Hom.:
Cov.:
33
AF XY:
AC XY:
4273
AN XY:
74466
show subpopulations
African (AFR)
AF:
AC:
1061
AN:
41576
American (AMR)
AF:
AC:
605
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
AC:
171
AN:
3470
East Asian (EAS)
AF:
AC:
443
AN:
5186
South Asian (SAS)
AF:
AC:
559
AN:
4822
European-Finnish (FIN)
AF:
AC:
1085
AN:
10612
Middle Eastern (MID)
AF:
AC:
21
AN:
294
European-Non Finnish (NFE)
AF:
AC:
4200
AN:
68026
Other (OTH)
AF:
AC:
124
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
408
816
1224
1632
2040
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
104
208
312
416
520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
346
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.